Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 Vincristine 3 Vinblastine 3 Rituximab 3 Prednisone 3 Nivolumab 3 Gemcitabine 3 Dacarbazine 3 Bleomycin 3 pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Cisplatin 2 Brentuximab Vedotin 2 Blood Specimen Collection 2 treosulfan 1 tislelizumab 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡